Health and Fitness Health and Fitness
Wed, August 24, 2011
Tue, August 23, 2011
Mon, August 22, 2011
Sat, August 20, 2011
Fri, August 19, 2011
Thu, August 18, 2011
Wed, August 17, 2011
[ Wed, Aug 17th 2011 ] - Market Wire
PPD???????BioDuro?????
Tue, August 16, 2011
Mon, August 15, 2011
Fri, August 12, 2011
Thu, August 11, 2011
Wed, August 10, 2011
Tue, August 9, 2011
Mon, August 8, 2011
Sun, August 7, 2011
Sat, August 6, 2011
Fri, August 5, 2011
Thu, August 4, 2011
Wed, August 3, 2011
Tue, August 2, 2011
Mon, August 1, 2011
Sun, July 31, 2011
Fri, July 29, 2011
Thu, July 28, 2011
Wed, July 27, 2011
[ Wed, Jul 27th 2011 ] - Market Wire
00 AM EDT
Tue, July 26, 2011
Mon, July 25, 2011
Sat, July 23, 2011
Fri, July 22, 2011
Thu, July 21, 2011

Transcept Pharmaceuticals to Report Second Quarter 2011 Financial Results, and Host Conference Call on August 11, 2011


Published on 2011-08-05 04:01:54 - Market Wire
  Print publication without navigation


Transcept Pharmaceuticals to Report Second Quarter 2011 Financial Results, and Host... -- POINT RICHMOND, Calif., Aug. 4, 2011 /PRNewswire/ --

Transcept Pharmaceuticals to Report Second Quarter 2011 Financial Results, and Host Conference Call on August 11, 2011

[ ]

POINT RICHMOND, Calif., Aug. 4, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: [ TSPT ]), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Thursday, August 11, 2011 at 4:30 p.m. Eastern Time to discuss its second quarter 2011 financial results. The conference call will follow the release of the Transcept second quarter 2011 financial results after the close of market that day.

Conference Call Information
Date: Thursday, August 11, 2011
Time: 4:30 p.m. EDT
Dial-in (U.S.): 877-638-4558
Dial-in (International): 914-495-8537

A simultaneous webcast of the conference call will be available on the Investors section of the Transcept website at [ www.transcept.com ]. A replay of this webcast will be available on the website shortly after the conclusion of the call through October 31, 2011.

A telephone replay of the conference call will be available shortly after the conclusion of the call through August 14, 2011. The replay telephone number is 855.859.2056 (U.S.) or 404.537.3406 (International), replay passcode: 84304811.

About Transcept

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Transcept is developing Intermezzo® (zolpidem tartrate sublingual tablet) as a prescription sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. Transcept is also developing TO-2061, a low dose ondansetron augmentation therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to treatment with approved first-line pharmacotherapy. For further information, please visit the Transcept website at: [ www.transcept.com ].

Contact:
Transcept Pharmaceuticals, Inc.
Greg Mann
Director, Corporate Communications
(510) 215-3567
[ gmann@transcept.com ]

SOURCE Transcept Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.transcept.com ]


Publication Contributing Sources